Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Euronext NV (ENX.PA)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (€) Price Target (€) Rating
2022-03-3083.1595.00Buy
2022-05-1876.6097.00Buy
2022-09-2663.7894.00Buy
2023-06-0263.3087.00Buy
2023-07-3169.2591.00Buy
2024-02-1981.4594.00Buy
2024-06-0591.80106.00Buy
2024-07-2991.95110.00Buy
2024-09-13100.80115.00Buy
2025-01-13106.20130.00Buy
2025-02-18119.10139.00Buy
2025-03-05124.60145.00Buy
2025-04-07128.60160.00Buy
2025-05-16147.70162.00Buy

Disclosures

  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • An employee of UBS is an officer, director, or advisory board member of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.